{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:08:11Z","timestamp":1759777691366},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.trsl.2006.06.005","type":"journal-article","created":{"date-parts":[[2006,12,10]],"date-time":"2006-12-10T16:59:24Z","timestamp":1165769964000},"page":"309-314","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models"],"prefix":"10.1016","volume":"148","author":[{"given":"Guoqing","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2006.06.005_bib1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archotol.129.7.781","article-title":"Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model","volume":"129","author":"Cox","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4 Pt 1","key":"10.1016\/j.trsl.2006.06.005_bib2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00005537-200104000-00024","article-title":"The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma","volume":"111","author":"Cox","year":"2001","journal-title":"Laryngoscope"},{"key":"10.1016\/j.trsl.2006.06.005_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jtra.10033","article-title":"An anticopper antiangiogenic approach for advanced cancer in spontaneously occurring tumors, using tetrathiomolybdate: a pilot study in a canine animal mode","volume":"17","author":"Kent","year":"2004","journal-title":"J Trace Elem Exp Med"},{"key":"10.1016\/j.trsl.2006.06.005_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/sj.neo.7900218","article-title":"Radiotherapy and antiangiogenic TM in lung cancer","volume":"4","author":"Khan","year":"2002","journal-title":"Neoplasia"},{"key":"10.1016\/j.trsl.2006.06.005_bib5","first-page":"617","article-title":"Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma","volume":"2","author":"Pan","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.trsl.2006.06.005_bib6","first-page":"4854","article-title":"Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis","volume":"62","author":"Pan","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2006.06.005_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.neo.7900258","article-title":"Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma","volume":"4","author":"van Golen","year":"2002","journal-title":"Neoplasia"},{"key":"10.1016\/j.trsl.2006.06.005_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.lab.2005.07.004","article-title":"Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice","volume":"146","author":"Hou","year":"2005","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2006.06.005_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1067\/mlc.2003.20","article-title":"Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice","volume":"141","author":"Brewer","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2006.06.005_bib10","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jinorgbio.2004.10.006","article-title":"Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis","volume":"98","author":"Brewer","year":"2004","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.trsl.2006.06.005_bib11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/153537020422900820","article-title":"Tetrathiomolybdate therapy protects against concanavalin A and carbon tetrachloride hepatic damage in mice","volume":"229","author":"Askari","year":"2004","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.trsl.2006.06.005_bib12","first-page":"419","article-title":"Tetrathiomolybdate protects against liver injury from acetaminophen in mice","volume":"4","author":"Ma","year":"2004","journal-title":"J Appl Res Clin Exp Ther"},{"key":"10.1016\/j.trsl.2006.06.005_bib13","first-page":"1","article-title":"Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study","volume":"6","author":"Brewer","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2006.06.005_bib14","first-page":"1666","article-title":"Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer","volume":"9","author":"Redman","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2006.06.005_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1582-4934.2003.tb00198.x","article-title":"Tetrathiomolybdate anticopper therapy for Wilson\u2019s disease inhibits angiogenesis, fibrosis and inflammation","volume":"7","author":"Brewer","year":"2003","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.trsl.2006.06.005_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1543-1150(03)00060-7","article-title":"Copper lowering therapy with tetrathiomolybdate produces antiangiogenic, anticancer, antifibrotic and antiinflammatory effects","volume":"1","author":"Brewer","year":"2003","journal-title":"Semin Integr Med"},{"key":"10.1016\/j.trsl.2006.06.005_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0022-2143(98)90039-7","article-title":"Treatment of Wilson\u2019s disease with zinc: XV long-term follow-up studies","volume":"132","author":"Brewer","year":"1998","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2006.06.005_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1517\/14656566.7.3.317","article-title":"Novel therapeutic approaches to the treatment of Wilson\u2019s disease","volume":"7","author":"Brewer","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.trsl.2006.06.005_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.lab.2005.01.007","article-title":"Treatment of Wilson\u2019s disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study","volume":"145","author":"Marcellini","year":"2005","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2006.06.005_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archneur.1991.00530130050019","article-title":"Initial therapy of patients with Wilson\u2019s disease with tetrathiomolybdate","volume":"48","author":"Brewer","year":"1991","journal-title":"Arch Neurol"},{"key":"10.1016\/j.trsl.2006.06.005_bib21","first-page":"380","article-title":"Treatment of Wilson\u2019s disease with zinc: X","volume":"120","author":"Yuzbasiyan-Gurkan","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2006.06.005_bib22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0024-3205(00)00667-6","article-title":"Modulation of adriamycin toxicity by tissue-specific induction of metallothionein synthesis in mice","volume":"67","author":"Satoh","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.trsl.2006.06.005_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1349-7006.1988.tb01605.x","article-title":"Specific reduction of toxic side effects of adriamycin by induction of metallothionein in mice","volume":"79","author":"Naganuma","year":"1988","journal-title":"Jpn J Cancer Res"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152440600404X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152440600404X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T21:01:10Z","timestamp":1555966870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193152440600404X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S193152440600404X"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2006.06.005","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}